Literature DB >> 33563002

Quantifying the Sex-Race/Ethnicity-Specific Burden of Obesity on Incident Diabetes Mellitus in the United States, 2001 to 2016: MESA and NHANES.

Natalie A Cameron1, Lucia C Petito2, Megan McCabe2, Norrina B Allen2, Matthew J O'Brien1,2, Mercedes R Carnethon2, Sadiya S Khan2,3.   

Abstract

Background Given the increasing prevalence of diabetes mellitus (DM) in the United States, estimating the effects of population-level increases in obesity on incident DM has substantial implications for public health policy. Therefore, we determined the population attributable fraction, which accounts for the prevalence and excess risk of DM associated with obesity. Methods and Results We included non-Hispanic White, non-Hispanic Black, and Mexican American participants without DM at baseline from MESA (Multi-Ethnic Study of Atherosclerosis) with available data on body mass index and key covariates from 2000 to 2017 to calculate unadjusted and adjusted (age, study site, physical activity, diet, income, and education level) hazard ratios (HR) for obesity-attributable DM. We calculated national age-adjusted prevalence estimates for obesity using data from NHANES (National Health and Nutrition Examination Survey) in 4 pooled cycles (2001-2016) among adults with similar characteristics to MESA participants. Last, we calculated unadjusted and adjusted population attributable fractions from the race/ethnic and sex-specific HR and prevalence estimates. Of 4200 MESA participants, the median age was 61 years, 46.8% were men, 53.9% were non-Hispanic White, 32.9% were non-Hispanic Black, and 13.3% were Mexican. Among MESA participants, incident DM occurred in 11.6% over a median follow-up of 9.2 years. The adjusted HR for obesity-related DM was 2.7 (95% CI, 2.2-3.3). Adjusted population attributable fractions were 0.35 (95% CI, 0.29-0.40) in 2001 to 2004 and 0.41 (95% CI, 0.36-0.46) in 2013 to 2016, and greatest among non-Hispanic White women. Conclusions The contribution of obesity towards DM in the population remains substantial and varies significantly by race/ethnicity and sex, highlighting the need for tailored public health interventions to reduce obesity. Registration URL: https://www.clinicaltrials.gov; Unique identifiers: NC00005487, NCT00005154.

Entities:  

Keywords:  diabetes mellitus; obesity; population attributable fraction

Year:  2021        PMID: 33563002     DOI: 10.1161/JAHA.120.018799

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


  5 in total

Review 1.  Sex Differences in Cardiovascular Consequences of Hypertension, Obesity, and Diabetes: JACC Focus Seminar 4/7.

Authors:  Judith G Regensteiner; Jane E B Reusch
Journal:  J Am Coll Cardiol       Date:  2022-04-19       Impact factor: 27.203

Review 2.  Epigenetics in Precision Nutrition.

Authors:  Xiang Li; Lu Qi
Journal:  J Pers Med       Date:  2022-03-28

3.  Pasos Hacia La Salud II: study protocol for a randomized controlled trial of a theory- and technology-enhanced physical activity intervention for Latina women, compared to the original intervention.

Authors:  Andrea S Mendoza-Vasconez; Tanya Benitez; Shira Dunsiger; Kim M Gans; Sheri J Hartman; Sarah E Linke; Britta A Larsen; Dorothy Pekmezi; Bess H Marcus
Journal:  Trials       Date:  2022-08-01       Impact factor: 2.728

4.  Evaluation of a civic engagement approach to catalyze built environment change and promote healthy eating and physical activity among rural residents: a cluster (community) randomized controlled trial.

Authors:  Rebecca A Seguin-Fowler; Karla L Hanson; Deyaun Villarreal; Chad D Rethorst; Priscilla Ayine; Sara C Folta; Jay E Maddock; Megan S Patterson; Grace A Marshall; Leah C Volpe; Galen D Eldridge; Meghan Kershaw; Vi Luong; Hua Wang; Don Kenkel
Journal:  BMC Public Health       Date:  2022-09-04       Impact factor: 4.135

5.  Evaluation of anthropometric indices as a predictor of diabetes in Dong and Miao ethnicities in China: A cross-sectional analysis of China Multi-Ethnic Cohort Study.

Authors:  Qianyuan Yang; Yalan Liu; Zhaofeng Jin; Leilei Liu; Zhiping Yuan; Degan Xu; Feng Hong
Journal:  PLoS One       Date:  2022-03-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.